Certified by Founder Lodge
Catalio Capital Management
United States - New York, NY
INVESTOR
1 Disclosed Funding Rounds $89,000,000
9 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Catalio Capital Management was created by George Petrocheilos and Dr. Jacob Vogelstein to invest in breakthrough biomedical technology companies created or referred by Catalio Capital Managem
| Company | Date | Round | Raised |
|---|---|---|---|
 xilis |
July, 13 ,2022 | Series A | $89,000,000 |
 Ensoma |
February, 06 ,2023 | Series B | $85,000,000 |
 Volastra Therapeutics |
March, 08 ,2023 | Series A | $60,000,000 |
 Septerna |
July, 18 ,2023 | Series B | $150,000,000 |
 Georgiamune Inc. |
August, 10 ,2023 | Series A | $75,000,000 |
 Star Therapeutics |
September, 05 ,2023 | Series C | $90,000,000 |
 NOETIK |
September, 08 ,2023 | Seed | $14,000,000 |
 Avalyn Pharma Inc. |
September, 28 ,2023 | Series C | $175,000,000 |
 Iambic Therapeutics |
October, 06 ,2023 | Series B | $100,000,000 |
dezerv.
FalconX
Kristal.AI
Finary
Savart
Scorability | $11,000,000 | (Oct 18, 2023)
Hallmark Health Care Solutions | Undisclosed Amount | (Oct 18, 2023)
Cloover | $7,388,000 | (Oct 18, 2023)
Yardstik | $12,000,000 | (Oct 18, 2023)
Anonybit | $3,000,000 | (Oct 18, 2023)
